SG
RCPI

Somerset Group’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Somerset Group’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-400
Closed -$3K – 78
2014
Q3 		$3K Hold
400
– – ﹤0.01% 73
2014
Q2 		$6K Buy
+400
New +$6.94K 0.01% 75

Other funds holding RCPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Somerset Group's RCPI Position: Q4 2014 in Review

Somerset Group sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2014, closing a stake of 400 shares — an estimated $3K sold.

Somerset Group first reported a position in RCPI in Q2 2014 and held it in 2 quarters. The position peaked at $6K in Q2 2014. 55 funds tracked by Wall St. Rank hold RCPI as of Q4 2014.

  • Somerset Group reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Somerset Group sold 400 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2014, an estimated $3K.
  • Somerset Group first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 2 quarters.
  • Somerset Group's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $6K in Q2 2014.
  • 55 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2014.

Based on Somerset Group's 13F filing for Q4 2014, filed 9 Feb 2015.